Nuveen Asset Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,719
| Closed | -$203K | – | 3482 |
|
|
2024
Q1 | $203K | Hold |
13,719
| – | – | ﹤0.01% | 3183 |
|
|
2023
Q4 | $184K | Hold |
13,719
| – | – | ﹤0.01% | 3227 |
|
|
2023
Q3 | $169K | Hold |
13,719
| – | – | ﹤0.01% | 3065 |
|
|
2023
Q2 | $169K | Buy |
+13,719
| New | +$169K | ﹤0.01% | 3105 |
|
|
2019
Q3 | – | Sell |
-602,214
| Closed | -$2.87M | – | 3278 |
|
|
2019
Q2 | $2.87M | Buy |
+602,214
| New | +$2.87M | ﹤0.01% | 2259 |
|